Next, we used paired peripheral (PP) breast tissues obtained from the same patient with breast tumour.
CaSR has been reported to be widely expressed in several mammalian tissues, including tissues that are not clearly involved in Ca2+ metabolism such as brain, lens epithelial cells, pituitary gland, bone marrow, peripheral blood, breast ductal cells, pancreas, keratinocytes, ovarian surface epithelial cells, parathyroid gland stem cells and the gastrointestinal system [32], [33], [39], [41] [43].
Aromatase inhibitors/inactivators act by lowering peripheral and breast tissue estrogen levels.
In the present study, we thus contrasted the aluminum levels of central and peripheral areas of breast carcinomas and the adjacent normal breast tissues in an unprecedentedly large set of patients.
The percentage of DCs, identified as Lin-/HLA-DR+ cells, in the mononuclear cell population was significantly lower in the peripheral blood of breast cancer patients compared with healthy controls (breast cancer: 0.87±0.04% (mean±s.e.m). of the mononuclear cells vs controls: 1.45±0.06%; P<0.001).
The AdnaTest BreastCancerSelect/AdnaTest BreastCancer-Detect kit (AdnaGen AG) used by Fehm and colleagues was developed for the enrichment of CTCs from peripheral blood of breast cancer patients, followed by detection of breast cancer-associated gene expression in immunomagnetically enriched tumor cells by reverse transcription and PCR [ 1].
The objective of the present study was to compare the aluminum levels in the central and peripheral areas of breast carcinomas with those in the adjacent normal breast tissues, and to identify patient and/or tumor characteristics associated with these aluminum levels.
However, whether reduced mtDNA in peripheral blood of breast cancer patients could potentially affect the outcome of endocrine treatment of breast cancer remains unknown.
However, it is worth mentioning that it was designed to evaluate differences in aluminum concentrations between central and peripheral areas of breast tumors, but not to assess the differences in aluminum concentrations across breast quadrants.
To develop a specific, reliable assay for detecting circulating tumor cells (CTC) in peripheral blood of breast cancer patients.
